Furthermore, SIVA-1 overexpression with DDP treatment synergistically inhibited tumor growth <i>in vivo</i> by increasing PCBP1 and decreasing Bcl-2 and Bcl-xL expression. The gene discussed is BCL2L1; the disease is neoplasm.